Saudi FDA Wants Device & Drug Firms To Report Payments To Doctors, Health Institutions
Executive Summary
The Saudi Food and Drug Authority has finalized the details of a new transparency initiative under which medical device and pharmaceutical companies will have to disclose their financial relationships with health-care professionals and institutions.
You may also be interested in...
When Do Device Companies Declare Payments To Professionals And Health-Care Organizations In Europe?
Europe recently saw a wave of disclosures published by pharmaceutical trade associations revealing the transfers of value made by companies to health-care professionals and organizations. In this article, attorneys at the law firm Baker & McKenzie – Julie Yeni, Julia Gillert, Chloe Cornet and Elina Angeloudi – discuss how the growing trend toward imposing greater transparency in the relationships between the health industry and health-care professionals continues, and what it will mean for the medical device sector in different countries across Europe and in Saudi Arabia.
Sunshine Website Goes Live With Some Context Sought By Industry
CMS releases data on $3.5 billion worth of payments made by drug and device companies to physicians and teaching hospitals in the last five months of 2013; an additional 199,000 payment records were not disclosed.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.